On September 6, 2018, with the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Akers Biosciences, Inc. the Board appointed Mr. Joshua Silverman as a Director of the Company for a term that expires at the Company’s 2019 Annual Meeting of Stockholders, or until his earlier death, disability, resignation or removal. The Board has yet to determine which Board committees, if any, Mr. Silverman will serve on.